Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib

Postgraduate Medical Journal

Volumn 78, Issue 921, 2002, Pages 439-440

  Kumar, N P ^a   Wild, G ^b   Ramasamy, K A ^a   Snape, Jeremy ^a  

^a KING S MILL HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; FUROSEMIDE; ISOPHANE INSULIN; METHOTREXATE; MIXTARD 30; PAROXETINE; PREDNISOLONE; ROFECOXIB;

ADULT; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEATH; DIABETES MELLITUS; DISEASE COURSE; HUMAN; LUNG EDEMA; MALE; RHEUMATOID ARTHRITIS; URTICARIA;

ANGIONEUROTIC EDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; FATAL OUTCOME; HEMORRHAGE; HUMANS; LACTONES; LUNG DISEASES; MALE; MIDDLE AGED; PULMONARY EDEMA; SULFONES;

EID: 0036326630     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.921.439     Document Type: Article

References (12)

1. Interpreting the clinical significance of the differential inhibition of cyclo-oxygenase 1 and cyclo-oxygenase 2
2. Basic biology and clinical application of specific cyclo-oxygenase-2 inhibitors
3. Focus: Rofecoxib (Vioxx)
4. Comparison of upper GI toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
5. Risk of cardiovascular events associated with selective COX-2 inhibitors
6. Role of clinical laboratory in allergy testing
7. Usefulness of uni CAP-tryptase fluoroimmunoassay in the diagnosis of anaphylaxis
8. Angioedema: Manifestations and management
9. Acquired angioedema
10. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs
11. Acquired angiaedema
12. Adverse upper GI effects of rofecoxib compared with NSAIDs